FDAFX Fees and Costs — Fidelity Advisor Freedom 2020 Fund, Class A
Data updated: 2026-08-24
The net expense ratio is 0.79%: a 0.54% management fee plus a 0.25% 12b-1 fee. This share class carries a maximum front-end sales load of 5.75%. In fiscal 2026 the fund paid $13K in broker commissions, 0.0012% of average net assets, and portfolio turnover was 17%.
FDAFX Fees and Expenses
Annual operating expenses and sales charges of FDAFX. Prospectus, as of May 31, 2026.
| Annual operating expenses | |
|---|---|
| Management fee | 0.54% |
| 12b-1 fee | 0.25% |
| Other expenses | 0.00% |
| Gross expense ratio | 0.79% |
| Fee waiver | — |
| Net expense ratio | 0.79% |
| Sales charges | |
|---|---|
| Max front load | 5.75% |
| Max deferred load | 0.00% |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | No |
| Waived fees subject to recoupment | No |
FDAFX Costs Over Time
On $10,000 invested in FDAFX, assuming 5% a year before costs, total costs come to $1,202 over 5 years, cutting the return by 2.06% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Sales charges | $575 | $575 | $575 |
| Fund expenses (net expense ratio 0.79%) | $78 | $244 | $425 |
| Trading costs (broker commissions) | $0 | $0 | $1 |
| Lost growth on money paid in costs | $29 | $103 | $202 |
| Total costs | $682 | $923 | $1,202 |
| Value after costs | $9,818 | $10,654 | $11,561 |
| Impact on return, per year | 6.82% | 2.87% | 2.06% |
FDAFX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending March 31, 2026.
- Explicit cost rate (commissions ÷ average net assets): 0.0012%
- Total broker commissions: $13K
- Bought from dealers (principal trades, not a cost): $11.9M
- Portfolio turnover (prospectus): 17%
- Securities lending: none during the year
FDAFX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| MORGAN STANLEY | $9K | 65.81% |
| JPMORGAN CHASE and CO | $2K | 12.15% |
| GOLDMAN SACHS GROUP INC (THE) | $1K | 10.07% |
| BARCLAYS PLC | $496 | 3.73% |
| UBS GROUP AG | $473 | 3.55% |
| BANK OF AMERICA CORPORATION | $439 | 3.30% |
| ROYAL BANK OF CANADA | $184 | 1.38% |
FDAFX Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| WELLS FARGO and CO | $5.5M | 46.04% |
| NOMURA HOLDINGS INC | $3.6M | 30.15% |
| JEFFERIES FINANCIAL GROUP INC | $1.4M | 12.00% |
| CITIGROUP INC | $1.1M | 9.49% |
| CITADEL SECURITIES GLOBAL HOLDINGS LLC | $257K | 2.16% |
| BANK OF MONTREAL QUE | $20K | 0.17% |
Fidelity Advisor Freedom 2020 Fund Share Classes
Net expense ratio and maximum front-end load of each share class, cheapest first.
| Ticker | Class | Net expense ratio | Front load |
|---|---|---|---|
| FOGLX | Class K6 | 0.28% | — |
| FIJLX | Class Z | 0.48% | none |
| FDIFX | Class I | 0.54% | none |
| FDAFX | Class A | 0.79% | 5.75% |
| FDTFX | Class M | 1.04% | 3.50% |
| FDCFX | Class C | 1.54% | none |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.